Scholar Rock Holding SRRK
NASDAQ SRRK
$48.77 +1.02 (+2.14%)
As of: Sep 30, 2026 · 2:39 PM EDT

Scholar Rock Holding (SRRK) Operating Expenses (2017 - 2026)

Updated

Scholar Rock Holding (SRRK) posted Operating Expenses of $108.9 million for Q2 2026, down 2.9% from $112.11 million a year earlier but up 6.7% from the prior quarter.

Analysis

Scholar Rock Holding (SRRK) Operating Expenses (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Scholar Rock Holding was $406.36 million, up 25.7% year-over-year; for FY2025, it was $384.65 million, up 52.6% from FY2024.

  • Annual Operating Expenses has increased for eight consecutive years, with a five-year compound annual growth rate of 30.3% (FY2020 to FY2025).
  • In prior years, Scholar Rock Holding's Operating Expenses was $252.05 million in FY2024 (+47.1%), $171.3 million in FY2023 (+2.2%), $167.56 million in FY2022 (+12.7%) and $148.74 million in FY2021 (+45.4%).
  • Quarterly Operating Expenses has run from a low of $39.08 million in Q2 2023 to a high of $112.11 million in Q2 2025 over five years.
  • On a year-over-year basis, Operating Expenses increased in seven of the last eight quarters, with growth averaging 41.9%.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q2 2025, with growth of 88.4%; the weakest was Q2 2023, with a decline of 9.4%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $102.02 million (Q1 2026), $91.9 million (Q4 2025) and $103.55 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Scholar Rock Holding 5.81 Bn 5.81 Bn - 108.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.90 Mn
Mar 31, 2026 102.02 Mn
Dec 31, 2025 91.90 Mn
Sep 30, 2025 103.55 Mn
Jun 30, 2025 112.11 Mn
Mar 31, 2025 77.09 Mn
Dec 31, 2024 69.36 Mn
Sep 30, 2024 64.78 Mn
Jun 30, 2024 59.50 Mn
Mar 31, 2024 58.42 Mn
Dec 31, 2023 48.03 Mn
Sep 30, 2023 43.67 Mn
Jun 30, 2023 39.08 Mn
Mar 31, 2023 40.51 Mn
Dec 31, 2022 40.43 Mn
Sep 30, 2022 43.86 Mn
Jun 30, 2022 43.15 Mn
Mar 31, 2022 40.13 Mn
Dec 31, 2021 39.41 Mn
Sep 30, 2021 42.54 Mn
API Access

Scholar Rock Holding Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=SRRK&period=max&api_key=YOUR_API_KEY